Blog Post

Diabeets.in > News > Uncategorized > Rare diseases: congenital hyperinsulinism – Emergency Live International

Rare diseases: congenital hyperinsulinism – Emergency Live International

Emergency Live – Pre-Hospital Care, Ambulance Services, Fire Safety and Civil Protection Magazine
Early diagnosis is essential to reduce the risk of neurological damage.
Congenital hyperinsulinism is a rare disease caused by a hyperplasia of the pancreatic β-cell that results in uncontrolled and excessive insulin secretion relative to contemporary plasma glucose levels.
It is the most frequent cause of severe and persistent hypoglycaemia in infants and early childhood.
It can, however, begin at any age of life.
Recurrent hypoglycaemia places patients at risk of permanent neurological damage.
The signs and symptoms of congenital hyperinsulinism are an expression of glucose deficiency in the central nervous system
Based on glycaemic levels, one distinguishes between neurogenic and neuroglycaemic symptoms.
Neurogenic symptoms are vegetative symptoms that appear when blood glucose levels fall below 60 mg/dl and are characterised by pallor, algid sweating, hyporeactivity, drowsiness, headache, palpitations, anxiety, dizziness, or tremors, paresthesias, hunger, irritability. The infant may present with faint crying, hypotonia, cyanosis, pallor, hypovalid sucking, hypothermia.
Neuroglycopenic symptoms appear when blood glucose falls below 50 mg/dl, manifest as sensory disturbances, convulsions and coma, and are an expression of cerebral dysfunction due to energy deficiency.
Genetic causes:
Acquired causes:
The diagnosis is based on the finding of non-ketotic hypoglycaemia, with suppressed NEFA (non-esterified fatty acids), inappropriately responding to glucagon.
The analysis is performed on a critical sample, taken at the time of spontaneous hypoglycaemia or at the end of a fasting test.
Another important element, particularly in the neonatal period, is the high glucose requirement needed to maintain normoglycaemia.
Emergency therapy aims to rapidly restore blood glucose values to normal (70-100 mg/dl) and is based on the administration of intravenous glucose solution in combination with a carbohydrate-rich diet.
In severe cases, it is necessary to place a central venous access to deliver highly concentrated glucose solutions, insert a naso-gastric tube or perform a gastrostomy to ensure hyperglucidic feeding.
Intravenous administration of glucagon may also be necessary to reduce the glucose requirement, thereby reducing water overload.
Long-term therapy is aimed at preventing brain damage and promoting normal psychomotor development of the child, encouraging normal eating behaviour, ensuring adequate fasting tolerance, and maintaining the best possible quality of life.
It is based on drugs that reduce insulin secretion: diazoxide is the drug of first choice, orally. In case of non-responsiveness to diazoxide, somatostatin analogues (subcutaneous octreotide, slow-release LAR octreotide by intramuscular injection) are used in combination with a hyperglucidic diet, often with the addition of maltodextrins or maize starch.
The diagnostic algorithm involves the interpretation of biochemical, genetic and imaging analyses (18Fluoro-DOPA PET/TC) to differentiate focal and diffuse forms of congenital hyperinsulinism.
Focal forms are an elective indication for partial pancreas resection surgery, which definitively cures the disease.
In contrast, for diffuse forms of hyperinsulinism, subtotal pancreasectomy surgery is only indicated in severe cases that do not respond to pharmacological and nutritional therapy.
This is a demolitive operation, with up to 98% of the pancreas removed, which does not guarantee recovery from hyperinsulinism and puts patients at high risk of developing insulin-dependent diabetes and exocrine pancreatic insufficiency.
RARE DISEASES? TO LEARN MORE VISIT THE UNIAMO – ITALIAN FEDERATION OF RARE DISEASES BOOTH AT EMERGENCY EXPO
In some severe non-responsive cases caused by mutations in the glucokinase gene, the ketogenic diet has proved effective in recovering intellectual disability and epilepsy.
The follow-up of patients involves serious checks with the intermittent use of continuous home blood glucose monitoring by means of a glycaemic holter, a very useful tool in personalising medical and nutritional therapy.
Patients also undergo periodic neuropsychological assessments to verify the effects of treatment on the development of the central nervous system, the early detection of any disabilities, and the timely initiation of rehabilitation courses.
Congenital hyperinsulinism, if not diagnosed and treated early, can cause permanent neurological damage, resulting in intellectual disability, epilepsy, cortical blindness and cerebral palsy.
Rapid diagnosis and the implementation of timely and specific normoglycaemic therapy can effectively prevent neurological damage, ensuring a good quality of life for the patient and family.
Therefore, the identification of at-risk individuals, early diagnosis and referral of patients to multidisciplinary referral centres is crucial.
Emergency Live Even More…Live: Download The New Free App Of Your Newspaper For IOS And Android
Rare Diseases: Von Hippel-Lindau Syndrome
Zika Linked To Guillain-Barre Syndrome In New Study
Down Syndrome And COVID-19, Research At Yale University
Rescue Training, Neuroleptic Malignant Syndrome: What It Is And How To Deal With It
Guillain-Barré Syndrome, Neurologist: ‘No Link To Covid Or Vaccine’
Facial Nerve Injuries: Bell’s Palsy And Other Causes Of Paralysis
Rare Diseases: Russian Economist Anatoly Chubais Diagnosed With Guillain Barré Syndrome
Ultrarare Diseases: First Guidelines For Malan Syndrome Published
Type 2 Diabetes: New Drugs For A Personalised Treatment Approach
The Diabetic Diet: 3 False Myths To Dispel
Paediatrics, Diabetic Ketoacidosis: A Recent PECARN Study Sheds New Light On The Condition
Orthopaedics: What Is Hammer Toe?
Hollow Foot: What It Is And How To Recognise It
Occupational (And Non-Occupational) Diseases: Shock Waves For The Treatment Of Plantar Fasciitis
Flat Feet In Children: How To Recognise Them And What To Do About It
Swollen Feet, A Trivial Symptom? No, And Here’s What Serious Diseases They May Be Associated With
Varicose Veins: What Are Elastic Compression Stockings For?
Diabetes Mellitus: Symptoms, Causes And Significance Of The Diabetic Foot
Diabetic Foot: Symptoms, Treatment And Prevention
Macroangiopathy: A Complication Of Diabetes
Diabetes: Doing Sport Helps Blood Glucose Control
Bambino Gesù
Prev Post
My eye dances: learning about nystagmus
Next Post
Spontaneous pneumothorax: discussing the collapse of the lungs
Diabetic microangiopathy: what it is and how to treat it
Inguinal hernia: symptoms and treatment
False myths and Hamletic doubts: does a low temperature cause a cold?
Calf cramps: could be peripheral obstructive arteriopathy
Latest articles
Brat: Italian contribution to mixed migration flows in Bosnia Herzegovina and…
Canadair crashed in Sicily: search for pilots resumed, Babcock’s condolences
Tragedy in Sicily, Canadair crashes to the ground: two pilots on board die
Senegal, the Red Cross plan for the migration emergency
Firefighting: Portugal to send six Kamov firefighting helicopters to Ukraine
Marketplace
Drones, the Rome Drone Conference 2022 opens tomorrow
Drones for Emergency and Civil Protection: Venari and heliguy develop a support…
OFSEC 2022: the Oman event on fire prevention, safety and protection
MERET Emergency Backpacks, Spencer’s catalogue is enriched with further…
Mariani Fratelli introduces the Volkswagen Crafter ambulance
Emergency Live is the only multilingual magazine dedicated to people involved in rescue and emergency. As such, it is the ideal medium in terms of speed and cost for trading companies to reach large numbers of target users; for example, all companies involved in some way in the equipping of specialised means of transport. From vehicle manufacturers to companies involved in equipping those vehicles, to any supplier of life- saving and rescue equipment and aids.
Emergency Live
Piazzale Badalocchio 9/b, 43126 Parma (PR) – Italy
Phone: +39 340 2246247
VAT Number: IT02277610347
Write us: go to the form mail
This website is not intended for the purpose of providing medical advice. All information, content, and material is for information and educational purposes and are not intended to serve as a substitute for the consultation, diagnosis, and/or medical treatment of a qualified physician or healthcare provider.
All the contents inside this website are addressed to EMS, Rescue and Medical professionals. All the information in the following pages are focused on the health sector, medical devices, pharmaceutical products or products inside these categories, and they request the use of a professional of the health sector.

source

Leave a comment

Your email address will not be published. Required fields are marked *